SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (BIOR) (“Biora” or the “Company”), a biotech company developing smart pill-based therapeutic platforms, today announced it has ...
Biora Therapeutics announces a Chapter 11 filing to support a sale process and secure up to $10.25 million in financing. Biora Therapeutics, Inc., a biotech company focused on developing smart ...
NEW HAVEN, Conn., Dec. 17 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION), a pharmaceutical company focused on the development of ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
SAN FRANCISCO, March 23, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has ...
Finch Therapeutics Group, Inc. has filed for bankruptcy, along with three related companies. The Boston-based company’s decision comes after a 95% workforce reduction in 2023. The biotechnology ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies ...
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies ...
On Sunday, Athenex Inc ATNX and certain of its subsidiaries voluntarily filed for Chapter 11 proceedings. Athenex agreed with its lenders to move forward with an expedited sale process of its assets, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results